Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors | 70 |
| A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors | 45 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors | 1 | 5 | 1 | 5 | 0 | 3 | 4 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 52 |
| Australia | 17 |
| China | 16 |
| Netherlands | 8 |
| Vietnam | 5 |
| France | 4 |
| Sweden | 2 |
| Ireland | 1 |
| Portugal | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 19 |
| Kaleen | 15 |
| Rotterdam | 8 |
| Zhengzhou | 8 |
| Fairfield | 6 |
| Hanoi | 5 |
| Beijing | 4 |
| Cambridge | 3 |
| Des Moines | 2 |
| New York | 2 |